[Effect of the vascular wall polypeptide factor vasonin on hemostatic function in an experimental peroxidation syndrome].
Kuzik BI, Mishchenko VP, Khavinson VKh, Morozov VG, Gritsaĭ NN · 1986 · Farmakologiia i toksikologiia · PMID 3817141
What does this source report?
Vasonin prevented hypercoagulation but did not prevent the underlying peroxidation syndrome.
- Population and setting
- Rabbits with diet-induced peroxidation syndrome
- Evidence type
- Animal / experimental
- Preparation
- See the original report; formulation details require verification.
- Source language
- English indexed abstract; original language:
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- This partial experimental effect does not establish vascular protection or a favorable bleeding-risk balance in humans.
- Full methods, reporting completeness and independent replication remain to be appraised.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Review depth: Abstract reviewed
Source access and review scope
Primary citation and indexed abstract reviewed through Europe PMC. Full article not appraised.
Recorded source-check date: 2026-10-05. This date does not imply a completed systematic review.
Source provenance: Original journal report
Cite and trace this record
Original source: Kuzik BI, Mishchenko VP, Khavinson VKh, Morozov VG, Gritsaĭ NN. [Effect of the vascular wall polypeptide factor vasonin on hemostatic function in an experimental peroxidation syndrome]. Farmakologiia i toksikologiia · PMID 3817141 1986.
Molekul research summary: https://molekul.io/research/audit-3817141. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry